Tag Archives: BioLife Solutions

Northland Securities Remains a Buy on BioLife Solutions (BLFS)

Northland Securities analyst Carl Byrnes maintained a Buy rating on BioLife Solutions (BLFS – Research Report) today and set a price target of $28.00. The company’s shares closed last Tuesday at $17.59. According to TipRanks.com, Byrnes is ranked 0 out

H.C. Wainwright Remains a Buy on BioLife Solutions (BLFS)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on BioLife Solutions (BLFS – Research Report) today and set a price target of $17.00. The company’s shares closed last Wednesday at $15.90. According to TipRanks.com, Selvaraju is a top 100

Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS), Regeneron (NASDAQ: REGN) and Nevro Crop (NYSE: NVRO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioLife Solutions (BLFS – Research Report), Regeneron (REGN – Research Report) and Nevro Crop (NVRO – Research Report). BioLife Solutions (BLFS) In a

BioLife Solutions (BLFS) Gets a Buy Rating from H.C. Wainwright

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on BioLife Solutions (BLFS – Research Report) today and set a price target of $17.00. The company’s shares closed last Monday at $11.47. According to TipRanks.com, Selvaraju is a 5-star analyst

BioLife Solutions (BLFS) Gets a Buy Rating from B.Riley FBR

B.Riley FBR analyst Marc Wiesenberger maintained a Buy rating on BioLife Solutions (BLFS – Research Report) today and set a price target of $22.00. The company’s shares closed last Friday at $10.54. According to TipRanks.com, Wiesenberger is a 5-star analyst

B.Riley FBR Reaffirms Their Buy Rating on BioLife Solutions (BLFS)

B.Riley FBR analyst Marc Wiesenberger maintained a Buy rating on BioLife Solutions (BLFS – Research Report) today and set a price target of $24.00. The company’s shares closed last Monday at $12.25, close to its 52-week low of $11.89. According